A newly surfaced internal memo from the U.S. Food and Drug Administration (FDA) has sparked debate after chief medical and scientific officer Vinay Prasad stated that COVID-19 vaccinations may have contributed to at least 10 cases of fatal heart inflammation in children. According to the memo, seen by Reuters, Prasad said the staff’s preliminary review suggested “likely, probable, or possible” vaccine attribution in these deaths. He described the findings as significant, noting it would mark the first time the FDA acknowledged potential fatal vaccine-related cases in American children.
The analysis reviewed 96 child deaths reported between 2021 and 2024. While it did not identify the children’s underlying medical conditions or the vaccine manufacturers involved, Prasad said that the early assessment found no fewer than 10 cases potentially linked to COVID-19 vaccination. He added that examining deaths involving children aged 7 to 16 was especially difficult.
Health Secretary Robert F. Kennedy Jr. has recently shifted U.S. vaccine policy, restricting access to COVID-19 vaccines to individuals 65 and older and those with certain conditions. Kennedy, long known for his skepticism toward vaccines, has criticized past vaccine policies promoted under both the Trump and Biden administrations.
Experts have urged caution in interpreting the memo. The FDA’s assessment has not been peer-reviewed or published in a medical journal, and critics—including UC Law San Francisco professor Dorit Reiss—argue that policy changes should not stem from unpublished investigations. Reiss also noted Prasad is not a vaccine specialist.
Despite concerns raised in the memo, FDA Commissioner Marty Makary emphasized that COVID-19 vaccines were highly effective for older adults, especially when matched to circulating variants. Recent research also supports the benefits of updated vaccines in reducing severe illness and hospitalization among high-risk groups.
CDC data shows 1,071 U.S. children aged 5 to 18 died from COVID-19 between early 2020 and mid-2023. Prasad argued that it remains unclear how vaccination influenced those outcomes, stating that voluntary reporting and unknown prevention metrics complicate comparisons.
The memo is expected to fuel continued discussion ahead of an upcoming CDC vaccine committee meeting.


Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Trump Orders Warning Signs Outside Smithsonian Museum Over ‘Anti-American’ Exhibits
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Colombia President Abelardo De La Espriella Pledges Drug Crackdown, Economic Reforms
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds
Bezalel Smotrich Faces Election Battle as Israel’s Far-Right Vote Fractures
Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
White House: No Weaponized Drones Seized at FIFA World Cup Venues Despite 700 Recoveries
AI Data Center Boom Faces New Risks as Public Backlash and Policy Scrutiny Grow
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Mark Carney Jokes About Teleprompter, Takes Swipe at Trump
US Continues Ukraine Patriot Missile Production Talks Despite Trump Doubts
Russian Strikes Kill Six in Eastern and Northern Ukraine, Dozens Injured
US Supreme Court Lets $655.5 Million Judgment Against Palestinian Authorities Stand During Appeal 



